Answer
Aucatzyl (obecabtagene autoleucel) is for autologous intravenous use only and must be administered in a qualified treatment centre by a physician experienced in treating haematological malignancies and trained in its administration and patient management.
Sources for this answer
- AucatzylAutolus · emc · SmPC §4.2 Posology and method of administration · Version 2Document updated
Sources checked